Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.4%

232 terminated/withdrawn out of 1609 trials

Success Rate

80.6%

-6.0% vs industry average

Late-Stage Pipeline

10%

165 trials in Phase 3/4

Results Transparency

47%

456 of 963 completed trials have results

Key Signals

229 recruiting456 with results169 terminated63 withdrawn

Enrollment Performance

Analytics

N/A

769(61.1%)

Phase 2

200(15.9%)

Phase 4

108(8.6%)

Phase 1

103(8.2%)

Phase 3

57(4.5%)

Early Phase 1

22(1.7%)

1259Total

N/A(769)

Phase 2(200)

Phase 4(108)

Phase 1(103)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1609)

Showing 20 of 1609 trials

NCT07737275Not ApplicableNot Yet Recruiting

Screening With Portable X-rays for Rapid Recognition of TB

Role: lead

NCT07632833Not ApplicableNot Yet Recruiting

The Use of a Comfort Tote to Improve Recovery in Pediatric and Adolescent Patients After Surgery

Role: lead

NCT06472206Not ApplicableRecruiting

Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

Role: lead

NCT06903143Not ApplicableCompleted

Piloting a Biomarker-augmented Alcohol Screening, Brief Intervention, and Referral to Treatment (SBIRT) Program Among HIV-affected Adolescents and Young Adults in Zambia

Role: collaborator

NCT07629635Phase 3Not Yet Recruiting

Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy

Role: lead

NCT04524767Not ApplicableCompleted

Depression Screening in Black Churches

Role: lead

NCT05918029Phase 2Terminated

Bone in CKD Alkali Response (BICARb Pilot Trial)

Role: collaborator

NCT06121453Not ApplicableRecruiting

Adherence Intervention in Patients With Metastatic Breast Cancer

Role: lead

NCT06601933Phase 2Recruiting

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Role: lead

NCT07559955Not ApplicableNot Yet Recruiting

Adapting Youth Nominated Support Team (YST) to Prevent Suicide

Role: lead

NCT04614558Phase 2Active Not Recruiting

Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance

Role: lead

NCT05823844Phase 4Completed

Efficacy of Suvorexant on Post-operative Sleep Disturbance

Role: lead

NCT06950983Not ApplicableRecruiting

Navigating Financial and Health-Related Social Needs in Adolescent and Young Adult Cancer Survivors (AYA-NAV)

Role: lead

NCT05359562Not ApplicableRecruiting

How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD

Role: collaborator

NCT04873401Not ApplicableCompleted

Leveraging Social Networks to Increase COVID-19 Testing Uptake

Role: collaborator

NCT00552357Recruiting

Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation

Role: collaborator

NCT00457847Active Not Recruiting

Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation

Role: collaborator

NCT04464980Phase 2Active Not Recruiting

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Role: collaborator

NCT05977439Not ApplicableRecruiting

RECOVERS - Realigning Emotion and COgnition Via prEcision Regulation networkS

Role: collaborator

NCT07714681Not ApplicableCompleted

Developing and Testing a Brief Mindfulness Just-in-time Adaptive Intervention for Reducing Stress of Dementia Caregivers

Role: collaborator